Hao Ho

2.6k total citations · 1 hit paper
25 papers, 1.8k citations indexed

About

Hao Ho is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hao Ho has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Hao Ho's work include Cytokine Signaling Pathways and Interactions (7 papers), Cancer Genomics and Diagnostics (4 papers) and interferon and immune responses (3 papers). Hao Ho is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Cancer Genomics and Diagnostics (4 papers) and interferon and immune responses (3 papers). Hao Ho collaborates with scholars based in United States, Taiwan and Canada. Hao Ho's co-authors include E. H. Lennette, Nathalie J. Schmidt, Lionel B. Ivashkiv, Marvin C. Gershengorn, Xiaoyu Hu, Ian Clark‐Lewis, Anjali Varma, Elizabeth Geras‐Raaka, Taras T. Antoniv and Kyung‐Hyun Park‐Min and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Hao Ho

25 papers receiving 1.7k citations

Hit Papers

An Apparently New Enterovirus Isolated from Patients with... 1974 2026 1991 2008 1974 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Ho United States 16 659 559 516 463 455 25 1.8k
Toshihiko Ishii Japan 21 211 0.3× 371 0.7× 461 0.9× 769 1.7× 108 0.2× 41 1.5k
Marika De Acetis Italy 7 194 0.3× 182 0.3× 802 1.6× 713 1.5× 151 0.3× 7 1.7k
Mette Munch Denmark 17 66 0.1× 338 0.6× 340 0.7× 223 0.5× 128 0.3× 24 1.3k
Shinya Sakaguchi Austria 17 92 0.1× 428 0.8× 615 1.2× 1.2k 2.6× 99 0.2× 31 1.8k
John Tazelaar United States 23 142 0.2× 552 1.0× 1.5k 2.9× 268 0.6× 390 0.9× 32 2.4k
Hüseyin Firat France 27 238 0.4× 488 0.9× 911 1.8× 1.2k 2.7× 49 0.1× 55 2.3k
Troy Krahl United States 27 143 0.2× 409 0.7× 703 1.4× 1.3k 2.9× 149 0.3× 32 2.9k
Patricia A. Lodge United States 15 452 0.7× 234 0.4× 379 0.7× 710 1.5× 76 0.2× 28 1.3k
Andrea Merlo Italy 21 65 0.1× 354 0.6× 506 1.0× 1.1k 2.5× 61 0.1× 41 1.9k
Heidi Trusheim Germany 15 88 0.1× 80 0.1× 494 1.0× 214 0.5× 186 0.4× 19 1.3k

Countries citing papers authored by Hao Ho

Since Specialization
Citations

This map shows the geographic impact of Hao Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Ho more than expected).

Fields of papers citing papers by Hao Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Ho. The network helps show where Hao Ho may publish in the future.

Co-authorship network of co-authors of Hao Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Ho. A scholar is included among the top collaborators of Hao Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Ho. Hao Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ho, Hao, Sung‐Liang Yu, Hsuan‐Yu Chen, et al.. (2023). Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages. Lung Cancer. 184. 107352–107352. 2 indexed citations
3.
Ho, Chao‐Chi, Hao Ho, Sheng‐Fang Su, et al.. (2021). Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts. Theranostics. 11(19). 9667–9686. 26 indexed citations
4.
Su, Sheng‐Fang, Hao Ho, Ming‐Fang Wu, et al.. (2021). DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a smoking-associated malignancy index. Journal of Clinical Investigation. 131(16). 11 indexed citations
5.
Cheng, Jinjun, et al.. (2018). Chronic myeloid leukemia, BCRABL1‐positive with CALR and MPL mutations. International Journal of Laboratory Hematology. 40(3). e41–e42. 5 indexed citations
6.
Mukherjee, Sandeep, Scott R. Wheeler, Malini Sathanoori, et al.. (2016). Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors. Cancer Genetics. 209(4). 119–129. 6 indexed citations
7.
Ho, Hao, Alyza Skaist, Aparna Pallavajjala, et al.. (2016). NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells. Leukemia Research. 45. 1–7. 3 indexed citations
8.
Chen, Jie‐Fu, Hao Ho, Jake Lichterman, et al.. (2015). Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer. 121(18). 3240–3251. 92 indexed citations
9.
Johnson, Nicole, Shu Liu, Mathieu Lévesque, et al.. (2014). Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey. Oncogene. 34(21). 2801–2806. 31 indexed citations
10.
Salazar, Christian R., Fritz François, Yihong Li, et al.. (2011). Association between oral health and gastric precancerous lesions. Carcinogenesis. 33(2). 399–403. 47 indexed citations
11.
12.
Leslie, Kenneth, Sizhi Paul Gao, Marjan Berishaj, et al.. (2010). Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Research. 12(5). R80–R80. 68 indexed citations
13.
Ho, Hao, et al.. (2010). Management of Traumatic Facial Nerve Injuries. Facial Plastic Surgery. 26(6). 511–518. 14 indexed citations
14.
Ho, Hao & Lionel B. Ivashkiv. (2006). Role of STAT3 in Type I Interferon Responses. Journal of Biological Chemistry. 281(20). 14111–14118. 257 indexed citations
15.
Sun, Wei, Weifeng Xu, M Snyder, et al.. (2005). The Conserved Leu-724 Residue Is Required for Both Serine Phosphorylation and Co-activator Recruitment for Stat1-mediated Transcription Activation in Response to Interferon-γ. Journal of Biological Chemistry. 280(51). 41844–41851. 10 indexed citations
16.
Tassiulas, Ioannis, Xiaoyu Hu, Hao Ho, et al.. (2004). Amplification of IFN-α-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors. Nature Immunology. 5(11). 1181–1189. 81 indexed citations
19.
Ho, Hao, et al.. (1999). Glycosylation Is Important for Binding to Human Calcitonin Receptors. Biochemistry. 38(6). 1866–1872. 38 indexed citations
20.
Geras‐Raaka, Elizabeth, Anjali Varma, Hao Ho, Ian Clark‐Lewis, & Marvin C. Gershengorn. (1998). Human Interferon-γ–inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma–associated Herpesvirus G Protein–coupled Receptor. The Journal of Experimental Medicine. 188(2). 405–408. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026